You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer
|
|---|---|
| Published in |
JAMA Oncology, September 2019
|
| DOI | 10.1001/jamaoncol.2019.1856 |
| Pubmed ID | |
| Authors |
Nancy Y Yu, Adina Iftimi, Christina Yau, Nicholas P Tobin, Laura van 't Veer, Katherine A Hoadley, Christopher C Benz, Bo Nordenskjöld, Tommy Fornander, Olle Stål, Kamila Czene, Laura J Esserman, Linda S Lindström |
X Demographics
The data shown below were collected from the profiles of 121 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 25 | 21% |
| Japan | 10 | 8% |
| Spain | 4 | 3% |
| Brazil | 4 | 3% |
| Italy | 4 | 3% |
| United Kingdom | 4 | 3% |
| Venezuela, Bolivarian Republic of | 4 | 3% |
| France | 4 | 3% |
| Mexico | 3 | 2% |
| Other | 16 | 13% |
| Unknown | 43 | 36% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 77 | 64% |
| Scientists | 25 | 21% |
| Practitioners (doctors, other healthcare professionals) | 18 | 15% |
| Science communicators (journalists, bloggers, editors) | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 68 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 7 | 10% |
| Student > Ph. D. Student | 6 | 9% |
| Researcher | 6 | 9% |
| Other | 5 | 7% |
| Student > Master | 5 | 7% |
| Other | 14 | 21% |
| Unknown | 25 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 24% |
| Biochemistry, Genetics and Molecular Biology | 8 | 12% |
| Nursing and Health Professions | 3 | 4% |
| Computer Science | 3 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
| Other | 8 | 12% |
| Unknown | 28 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 109. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2024.
All research outputs
#393,563
of 25,793,330 outputs
Outputs from JAMA Oncology
#641
of 3,367 outputs
Outputs of similar age
#8,040
of 352,602 outputs
Outputs of similar age from JAMA Oncology
#29
of 92 outputs
Altmetric has tracked 25,793,330 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,367 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 84.0. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,602 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 92 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.